<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The presenting clinical characteristics and the results of therapy in 30 cases of American Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> are described </plain></SENT>
<SENT sid="1" pm="."><plain>Five patients presented with <z:e sem="disease" ids="C0277565" disease_type="Disease or Syndrome" abbrv="">localized disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The abdomen was the most frequent site of involvement (19 cases) </plain></SENT>
<SENT sid="3" pm="."><plain>Serum lactic dehydrogenase (LDH) levels closely correlated with extent of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> mass </plain></SENT>
<SENT sid="4" pm="."><plain>Of the 22 patients treated with large doses of parenteral <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, complete remission was achieved in 13 (59 per cent) </plain></SENT>
<SENT sid="5" pm="."><plain>Of these only four have had a relapse, <z:hpo ids='HP_0000001'>all</z:hpo> within 12 months of treatment </plain></SENT>
<SENT sid="6" pm="."><plain>The remainder are alive, free of disease and have not received any treatment for up to 80 months or more </plain></SENT>
<SENT sid="7" pm="."><plain>The site and volume of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> mass predicted for prolonged survival </plain></SENT>
<SENT sid="8" pm="."><plain>None of the six patients with bone marrow or central <z:mp ids='MP_0008912'>nervous</z:mp> system involvement remained <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-free </plain></SENT>
<SENT sid="9" pm="."><plain>A complete remission was achieved in 8 of 9 patients with presenting LDH levels of less than 700 IU/ml and they have remained free of disease, whereas only 4 of 13 patients with LDH levels greater than 700 IU/ml had a complete response and 3 of these had a relapse within 12 months </plain></SENT>
<SENT sid="10" pm="."><plain>In six cases, the massive <z:mp ids='MP_0010537'>tumor regression</z:mp> following chemotherapy was associated with serious metabolid consequences including <z:hpo ids='HP_0002153'>hyperkalemia</z:hpo> (six cases), <z:hpo ids='HP_0002901'>hypocalcemia</z:hpo>, <z:hpo ids='HP_0002905'>hyperphosphatemia</z:hpo> (one case) and <z:hpo ids='HP_0003128'>lactic acidosis</z:hpo> (one case) </plain></SENT>
<SENT sid="11" pm="."><plain>There were four <z:hpo ids='HP_0001699'>sudden deaths</z:hpo> in less than 48 hours after chemotherapy; two of these were attributable to <z:hpo ids='HP_0002153'>hyperkalemia</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> cases therw were large <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> masses and/or elevated serum LDH levels </plain></SENT>
</text></document>